SVCT Seneca Growth Capital Vct Plc

 
TIDMHYG TIDMSVCT 
 
 
   Seneca Growth Capital VCT Plc (the "Company") 
 
   5 October 2020 
 
   Net asset value ("NAV") update for the quarter ended 30 September 2020 
 
   The Directors and the Investment Manager of the Company, Seneca Partners 
Limited, have reviewed the valuation of the Company's portfolios as at 
30 September 2020. 
 
   Ordinary Shares 
 
   As at 30 September 2020, the unaudited NAV of an Ordinary share was 
37.6p per share. This is an increase of 1.8p from the previously 
published unaudited NAV as at 14 September 2020 of 35.8p and is due to 
the change in value of the Ordinary share pool's quoted investment 
Scancell Holdings Plc, net of the associated performance fee. As at 30 
September 2020, shares in Scancell Holdings Plc were valued at 16.5p (14 
September 2020: 15.0p). The Directors also reviewed the unquoted 
investments held in the portfolio and concluded that all valuations 
remain appropriate. 
 
   B Shares 
 
   The unaudited NAV of a B share as at 30 September 2020 was 90.4p per B 
share. This is an increase of 1.1p from the previously published 
unaudited NAV as at 30 June 2020 of 89.3p and is due to changes in the 
value of the quoted investments, as well as the impact of ordinary 
running costs incurred in the period. As at 30 September 2020, shares in 
SkinBioTherapeutics Plc were valued at 19.5p (30 June 2020: 16.7p) and 
shares in OptiBiotix Health Plc were valued at 51.0p (30 June 2020: 
49.0p). The Directors also reviewed the unquoted investments held in the 
portfolio and concluded that all valuations remain appropriate. 
 
   Quoted investments are valued at the closing bid prices on 30 September 
2020. 
 
   The Directors are not aware of any post period end events that would 
materially impact the Company itself or the value of investments held. 
 
   The information above is deemed by the Company to constitute inside 
information as stipulated under the Market Abuse Regulations (EU No. 
596/2014). Upon the publication of this announcement via a Regulatory 
Information Service this inside information is now considered to be in 
the public domain. 
 
   For further information, please contact: 
 
   John Hustler, Seneca Growth Capital VCT Plc at 
john.hustler@btconnect.com 
 
   Richard Manley, Seneca Growth Capital VCT Plc at 
Richard.Manley@senecapartners.co.uk 
 
 
 
 

(END) Dow Jones Newswires

October 05, 2020 02:00 ET (06:00 GMT)

Seneca Growth Capital Vct (LSE:SVCT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024

Seneca Growth Capital Vct (LSE:SVCT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024